54 072 54 072 (Hydroxyurea 500 mg)
Pill imprint 54 072 54 072 has been identified as Hydroxyurea 500 mg.
Hydroxyurea is used in the treatment of thrombocythemia; anemia, sickle cell; chronic myelogenous leukemia; polycythemia vera; cervical cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydroxyurea 500 mg is not subject to the Controlled Substances Act.
See also related documents.